Neurofibromatosis 2 - 25 Studies Found
Completed |
: Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors :
: 2014-03-26 : Drug: Endostatin Method of drug administration:continuous intravenous pumping; Dosage: 7.5mg/m2/d; Cours |
Recruiting |
: Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas :
: 2014-04-29 : Drug: Axitinib Other Name: Inlyta |
Recruiting |
: Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma :
: 2011-04-21 : Drug: RAD001, everolimus Adults: 10 mg p.o. daily dose, age 16 - 17: 3.0 mg/m2 p.o. daily |
No longer available |
: Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients :
|
Completed |
: Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) :
: 2010-09-01 :
|
Completed |
: NF2 Natural History Consortium :
|
Recruiting |
: Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors :
: 2010-10-15 |
Recruiting |
: Neurofibromatosis (NF) Registry Portal :
|